Studies report amplified GH pulse amplitude without disrupting the natural pulsatile release pattern, along with dose-dependent increases in circulating IGF-1 that persist for extended periods following subcutaneous administration
The peptide has also never been characterized in humans the way an approved drug is: there is no established human pharmacokinetic profile, no dose-ranging efficacy study, and no long-term safety dataset
Key Benefits of CJC-1295 Increases endogenous growth hormone and IGF-1 Promotes lean muscle growth and recovery Improves sleep quality and REM cycles Supports fat loss by enhancing metabolic rate May improve skin elasticity and reduce signs of aging Because it acts on your bodys natural feedback loop, CJC-1295 is considered safer and more sustainable than synthetic HGH especially when combined with peptides like Ipamorelin that enhance its effectiveness
R., Pola, P., D'Iddio, S., Zeviani, M., Didonato, S., and Corsi, M
Ipamorelin Mechanism Type: Ghrelin mimetic (GHS-R agonist) Action: Binds to ghrelin receptor to prompt gradual GH release Primary Benefit: Stable hormone regulation without affecting cortisol or prolactin This makes Ipamorelin a more balanced, restorative option for overall wellness and recovery
This experiment was performed in triplicate and the results were presented as the means SD
